Media Summary: RAISE and NASTAD's webinar, “LAI-ART: Questions for Session 2 - Factors affecting the choice of antiretroviral therapy GULF Presenter: Jean-Michel Molina, MD, PhD, Saint-Louis/Lariboisière Hospitals and University of Paris, France Lecture: Update on ...

Long Acting Hiv Drugs For Treatment Data And Potential Implementation Laura Waters - Detailed Analysis & Overview

RAISE and NASTAD's webinar, “LAI-ART: Questions for Session 2 - Factors affecting the choice of antiretroviral therapy GULF Presenter: Jean-Michel Molina, MD, PhD, Saint-Louis/Lariboisière Hospitals and University of Paris, France Lecture: Update on ... Lecture: Impact on Women's Health and Weight Gain Speaker: Steve H. discusses his experience being diagnosed with Title: Clinical Review: New RT Inhibitors – Doravirine Speaker:

In this live, 30-minute, uncertified educational video event, three interprofessional experts in Presenter: Charles Flexner, Johns Hopkins University School of

Photo Gallery

Long-Acting HIV Drugs for Treatment: Data and Potential Implementation - Laura Waters
Long-Acting HIV Drugs for Treatment: Data and Potential Implementation - Charles Flexner
Long acting ARV for treatment and prevention - clinical considerations | Laura Waters, MD, FRCP
Webinar: LAI-ART - Questions for Implementing Long-acting Medications in HIV Treatment Programs
Leveraging Reverse Transcriptase in HIV 2021 - Laura Waters
ARV toxicity and their management (including weight gain) - Laura Waters,MD
Session 3: Optimizing Clinical Implementation of Long-Acting Therapies | Full Livestream
Rio HIV Clinical Forum 2020 | Laura Waters - Comparative Side Effects Integrase Inhibitors
Long acting HIV drugs for treatment: what are the data? | Anton Pozniak, MD, FRCP
New delivery systems and long acting antiretroviral drugs | David Back, PhD
Long-Acting Cabotegravir / Rilpivirine for Individuals With Detectable Viral Loads
Update on Long Acting Therapeutic Options for HIV Treatment - Jean-Michel Molina, MD, PhD
Sponsored
Sponsored
View Detailed Profile
Long-Acting HIV Drugs for Treatment: Data and Potential Implementation - Laura Waters

Long-Acting HIV Drugs for Treatment: Data and Potential Implementation - Laura Waters

Clinical Pharmacology of Antiviral

Long-Acting HIV Drugs for Treatment: Data and Potential Implementation - Charles Flexner

Long-Acting HIV Drugs for Treatment: Data and Potential Implementation - Charles Flexner

Clinical Pharmacology of Antiviral

Sponsored
Long acting ARV for treatment and prevention - clinical considerations | Laura Waters, MD, FRCP

Long acting ARV for treatment and prevention - clinical considerations | Laura Waters, MD, FRCP

Lecture:

Webinar: LAI-ART - Questions for Implementing Long-acting Medications in HIV Treatment Programs

Webinar: LAI-ART - Questions for Implementing Long-acting Medications in HIV Treatment Programs

RAISE and NASTAD's webinar, “LAI-ART: Questions for

Leveraging Reverse Transcriptase in HIV 2021 - Laura Waters

Leveraging Reverse Transcriptase in HIV 2021 - Laura Waters

Dr.

Sponsored
ARV toxicity and their management (including weight gain) - Laura Waters,MD

ARV toxicity and their management (including weight gain) - Laura Waters,MD

Session 2 - Factors affecting the choice of antiretroviral therapy GULF

Session 3: Optimizing Clinical Implementation of Long-Acting Therapies | Full Livestream

Session 3: Optimizing Clinical Implementation of Long-Acting Therapies | Full Livestream

Session 3: Optimizing Clinical

Rio HIV Clinical Forum 2020 | Laura Waters - Comparative Side Effects Integrase Inhibitors

Rio HIV Clinical Forum 2020 | Laura Waters - Comparative Side Effects Integrase Inhibitors

Rio de Janeiro

Long acting HIV drugs for treatment: what are the data? | Anton Pozniak, MD, FRCP

Long acting HIV drugs for treatment: what are the data? | Anton Pozniak, MD, FRCP

Lecture:

New delivery systems and long acting antiretroviral drugs | David Back, PhD

New delivery systems and long acting antiretroviral drugs | David Back, PhD

Lecture: New delivery systems and

Long-Acting Cabotegravir / Rilpivirine for Individuals With Detectable Viral Loads

Long-Acting Cabotegravir / Rilpivirine for Individuals With Detectable Viral Loads

Dr. Monica Gandhi shares experience and

Update on Long Acting Therapeutic Options for HIV Treatment - Jean-Michel Molina, MD, PhD

Update on Long Acting Therapeutic Options for HIV Treatment - Jean-Michel Molina, MD, PhD

Presenter: Jean-Michel Molina, MD, PhD, Saint-Louis/Lariboisière Hospitals and University of Paris, France Lecture: Update on ...

Managing Toxicity in the Complex HIV Patient | Laura Waters MD, FRCP

Managing Toxicity in the Complex HIV Patient | Laura Waters MD, FRCP

Speaker:

Impact on Women’s Health and Weight Gain | Laura Waters, MD

Impact on Women’s Health and Weight Gain | Laura Waters, MD

Lecture: Impact on Women's Health and Weight Gain Speaker:

Long-Acting Injectables for HIV Prevention and Treatment

Long-Acting Injectables for HIV Prevention and Treatment

Cyril Gaultier, MD, FIDSA 2024

Patient Shares Experience with Long-Acting Regimen for HIV Treatment

Patient Shares Experience with Long-Acting Regimen for HIV Treatment

Steve H. discusses his experience being diagnosed with

Clinical Review: New RT Inhibitors – Doravirine - Laura Waters

Clinical Review: New RT Inhibitors – Doravirine - Laura Waters

Title: Clinical Review: New RT Inhibitors – Doravirine Speaker:

Round Table Discussion 3 | Clinical Implementation of Long-Acting Therapies

Round Table Discussion 3 | Clinical Implementation of Long-Acting Therapies

Round Table Discussion 3: Clinical

Optimizing Outcomes With Long-Acting Injectables for HIV

Optimizing Outcomes With Long-Acting Injectables for HIV

In this live, 30-minute, uncertified educational video event, three interprofessional experts in

The Long-Acting Pipeline for HIV Treatment - Charles Flexner, MD

The Long-Acting Pipeline for HIV Treatment - Charles Flexner, MD

Presenter: Charles Flexner, Johns Hopkins University School of